BIT:UBM - Ulisse Biomed Stock Price & Analysis

About Ulisse Biomed (BIT:UBM)

(BIT:UBM) Ulisse Biomed S.p.A., a healthcare biotech company, provides diagnostic platforms and products. The company through its Sagitta platform offers various tests, such as Ladymed/HPV Selfy for the detection of human papillomavirus (HPV); CoronaMelt, a diagnostic test for Sars- CoV-2; CoronaMelt Var, a diagnostic assay for the detection and genotyping of Sars-CoV-2 variants; and UlisseFaster, a reagent for the pre-treatment of biological samples. It also provides various tests and reagents for sexually transmitted diseases and HPV for oropharyngeal cancer. In addition, the company's platforms also comprise NanoHybrid, a DNA/PNA based multi-modal biomolecule platform to detect specific antibodies and protein analytes directly from serum or whole blood; and Aptavir platform to develop and produce synthetic nucleic acid molecules to limit the infectivity of pathogens. Ulisse Biomed S.p.A. was founded in 2015 and is based in Udine, Italy.

UBM Stock Price

Statistics Highlights (BIT:UBM)

Shares Outstanding	8.06M	Beta	-
Public Float	-	P/E Ratio	48.00
% Short of Float	-	Dividend (Yield)	-
Held by Insiders	15.75%	Ex-Dividend Date
Held by Institutions	2.72%	IPO Date	-

Explore More on "Statistics" Section

UBM Financial Summary

|


Revenue
EBITDA
Net Income
Total Assets
Total Cash
Total Debt


Revenue
EBITDA
Net Income
Total Assets
Total Cash
Total Debt

(BIT:UBM) Stock Price FAQs

What is Ulisse Biomed's 52-week change?

Ulisse Biomed (BIT:UBM) FAQ

How Much is Ulisse biomed Worth?

Ulisse biomed's worth today based on market capitalisation is €11.61M

How much dividend does Ulisse biomed Pay?

The current annualized dividend payout for UBM stock is €0.00, the dividend yield is 0.00% and the payout ratio is 0.00%.
View More Details on Ulisse biomed's "Dividend" Section

What is Ulisse biomed’s Price to Earning (PE) ratio?

Ulisse biomed has a Price to Earning (P/E) ratio of 48.00. UBM stock also has a Price to Sales (P/S) ratio of 41.41.

What is the Ulisse biomed's ticker?

Ulisse biomed trades on the Milan stock market in Italy under the ticker symbol "UBM". Ulisse biomed’s stock symbol can also be displayed as "BIT:UBM".

Who are the owners of Ulisse biomed?

Ulisse biomed (BIT:UBM) is owned by 2.72% institutional shareholders and by 15.75% insiders. The rest is owned by the public.
Explore More Details on Ulisse biomed's “Ownership” Section

Who are the key executives of Ulisse biomed (UBM)?

Ulisse biomed's key executive team includes the following managers:

Mr. Matteo Petti, CEO & Director (1982)
Ms. Bruna Marini, Co-founder, COO & Exec. Director (1985)
Mr. Rudy Ippodrino, Co-Founder & Chief Scientific Officer (NA)
Mr. Ferdinando Giuliani, Head of Bus. Devel. (NA)
Mr. Luigi Colombo, Exec. Director (1963)

What is Ulisse biomed’s Sector & Industry Classification?

Ulisse biomed (BIT:UBM) is classified under the "Healthcare" sector and under the "Biotechnology" industry.

How many employees work for Ulisse biomed?

Currently the number of employees working for Ulisse biomed is 3.

Where are Ulisse biomed's Headquarters?

Ulisse biomed (BIT:UBM) is headquartered in UD, Italy.

What are Ulisse biomed's Address and Phone Number?

Ulisse biomed’s mailing address is Via Cavour, 20, Udine, UD, Italy, 33100.
The company’s phone number is 39 04 03 75 75 40.

What is the official website for Ulisse biomed?

Ulisse biomed’s official website is https://www.ulissebiomed.com

Ulisse Biomed Stock (BIT:UBM)